Allogene Therapeutics Stock Forecast

Hold candidate since Jun 25, 2026

The Allogene Therapeutics stock price gained 0.488% on the last trading day (Thursday, 25th Jun 2026), rising from $2.05 to $2.06. During the last trading day the stock fluctuated 5.39% from a day low at $2.04 to a day high of $2.15. The price has risen in 7 of the last 10 days and is up by 15.73% over the past 2 weeks. Volume fell on the last day by -330 thousand shares and in total, 9 million shares were bought and sold for approximately $18.99 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -21.25% during the next 3 months and, with a 90% probability hold a price between $1.27 and $1.97 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

ALLO Signals & Forecast

The Allogene Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $2.02 and $2.05. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, June 22, 2026, and so far it has fallen -1.90%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Allogene Therapeutics stock

Allogene Therapeutics finds support from accumulated volume at $2.05 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.110 between high and low, or 5.39%. For the last week, the stock has had daily average volatility of 6.00%.

Our recommended stop-loss: $1.97 (-4.13%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 3 days ago.)

Trading Expectations (ALLO) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect Allogene Therapeutics Inc. to open at $2.08, and during the day (based on 14 day Average True Range), to move between $1.99 and $2.13, which gives a possible trading interval of +/-$0.139 (+/-6.96%) up or down from last closing price. If Allogene Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 6.96% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.05 (0.49%) than the resistance at $2.17 (5.34%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Allogene Therapeutics Inc. stock A Buy?

Allogene Therapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: 0.291 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 26, 2026 - $2.08 ( 1.13%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk